JAK2 and atherosclerosis: For instance, ApoE-null mice with myeloid-specific Jak2 deletion develop accelerated atherosclerosis (24) despite being protected against high-fat diet–induced obesity, systemic insulin resistance, and inflammation in liver and visceral adipose tissue (25).